196 related articles for article (PubMed ID: 16215764)
1. Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers.
Raitio A; Tuomas H; Kokkonen N; Salo T; Sorsa T; Hanemaaijer R; Oikarinen A
Arch Dermatol Res; 2005 Dec; 297(6):242-8. PubMed ID: 16215764
[TBL] [Abstract][Full Text] [Related]
2. Effect of smoking, abstention, and nicotine patch on epidermal healing and collagenase in skin transudate.
Sørensen LT; Zillmer R; Agren M; Ladelund S; Karlsmark T; Gottrup F
Wound Repair Regen; 2009; 17(3):347-53. PubMed ID: 19660042
[TBL] [Abstract][Full Text] [Related]
3. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
[TBL] [Abstract][Full Text] [Related]
4. Smoking affects diagnostic salivary periodontal disease biomarker levels in adolescents.
Heikkinen AM; Sorsa T; Pitkäniemi J; Tervahartiala T; Kari K; Broms U; Koskenvuo M; Meurman JH
J Periodontol; 2010 Sep; 81(9):1299-307. PubMed ID: 20450405
[TBL] [Abstract][Full Text] [Related]
5. The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis.
Górska R; Nedzi-Góra M
Arch Immunol Ther Exp (Warsz); 2006; 54(6):419-26. PubMed ID: 17122880
[TBL] [Abstract][Full Text] [Related]
6. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
[TBL] [Abstract][Full Text] [Related]
7. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
[TBL] [Abstract][Full Text] [Related]
8. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
[TBL] [Abstract][Full Text] [Related]
9. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
10. Salivary matrix metalloproteinase-8 in patients with and without coronary heart disease may indicate an increased susceptibility to periodontal disease.
Furuholm J; Sorsa T; Qvarnström M; Janket SJ; Tervahartiala T; Nuutinen P; Meurman JH
J Periodontal Res; 2006 Oct; 41(5):486-9. PubMed ID: 16953826
[TBL] [Abstract][Full Text] [Related]
11. Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.
Marcaccini AM; Novaes AB; Meschiari CA; Souza SL; Palioto DB; Sorgi CA; Faccioli LH; Tanus-Santos JE; Gerlach RF
Clin Chim Acta; 2009 Nov; 409(1-2):117-22. PubMed ID: 19751716
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-8/collagenase-2 in childhood otitis media with effusion.
Lauhio A; Rezes S; Tervahartiala T; Sziklai I; Pitkäranta A; Sorsa T
Ann Med; 2012 Feb; 44(1):93-9. PubMed ID: 21047154
[TBL] [Abstract][Full Text] [Related]
13. Do salivary and serum collagenases have a role in an association between obstructive sleep apnea syndrome and periodontal disease? A preliminary case-control study.
Nizam N; Basoglu OK; Tasbakan MS; Holthöfer A; Tervahartiala T; Sorsa T; Buduneli N
Arch Oral Biol; 2015 Jan; 60(1):134-43. PubMed ID: 25455127
[TBL] [Abstract][Full Text] [Related]
14. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma.
Gerlach RF; Demacq C; Jung K; Tanus-Santos JE
Clin Biochem; 2007 Jan; 40(1-2):119-23. PubMed ID: 17150202
[TBL] [Abstract][Full Text] [Related]
15. Collagen deposition in the subcutaneous tissue during wound healing in humans: a model evaluation.
Jørgensen LN
APMIS Suppl; 2003; (115):1-56. PubMed ID: 14625992
[TBL] [Abstract][Full Text] [Related]
16. Low serum level of pro-matrix metalloproteinase 2 correlates with aggressive behavior in breast carcinoma.
Kuvaja P; Talvensaari-Mattila A; Pääkkö P; Turpeenniemi-Hujanen T
Hum Pathol; 2006 Oct; 37(10):1316-23. PubMed ID: 16949931
[TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis.
Waas ET; Wobbes T; Lomme RM; DeGroot J; Ruers T; Hendriks T
Br J Surg; 2003 Dec; 90(12):1556-64. PubMed ID: 14648736
[TBL] [Abstract][Full Text] [Related]
19. Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease.
Yıldırım E; Kormi I; Başoğlu ÖK; Gürgün A; Kaval B; Sorsa T; Buduneli N
J Periodontal Res; 2013 Jun; 48(3):269-75. PubMed ID: 22967248
[TBL] [Abstract][Full Text] [Related]
20. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
Huang CY; Wu TC; Lin WT; Leu HB; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2006 Feb; 36(2):76-84. PubMed ID: 16436088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
